{"id":421,"date":"2019-10-03T21:09:59","date_gmt":"2019-10-03T21:09:59","guid":{"rendered":"https:\/\/mirm-pitt.net\/technologies\/?p=421"},"modified":"2019-10-03T21:09:59","modified_gmt":"2019-10-03T21:09:59","slug":"ligamend-resorbable-magnesium-ring-for-acl-reconstruction","status":"publish","type":"post","link":"https:\/\/mirm-pitt.net\/technologies\/2019\/10\/03\/ligamend-resorbable-magnesium-ring-for-acl-reconstruction\/","title":{"rendered":"LigaMend: Resorbable Magnesium Ring for ACL Reconstruction"},"content":{"rendered":"

Savio L-Y Woo, PhD, DSc, Deng<\/a>, <\/strong>Scientific PI
\n<\/em>Professor of Bioengineering
\n<\/em>Founder\/Director of Musculoskeletal Research Center<\/p>\n

Email:\u00a0<\/strong>slyw@pitt.edu<\/a>
\nPhone:<\/strong> (412) 648-2000
\nhttp:\/\/www.pitt.edu\/~msrc<\/a><\/p>\n

Patrick J. McMahon, MD<\/strong><\/a>
\n<\/em>Associate Professor of Bioengineering
\nFounder of McMahon Orthopedics & Rehabilitation<\/p>\n

Email:\u00a0<\/strong>mcmahonp@upmc.edu<\/a>
\nPhone:<\/strong> (412) 431-7342<\/p>\n

Katie Farraro, PhD<\/strong>
\nPostdoctoral Fellow<\/em><\/p>\n

Email:\u00a0<\/strong>kff@pitt.edu<\/a>
\nPhone:<\/strong> (412) 648-2000<\/p>\n

<\/a>Over 200,000 people each year in the US sustain an anterior cruciate ligament (ACL) injury during sports-related activities. More than two-thirds of patients with ACL injuries undergo surgical ACL reconstruction to re-stabilize their knee, representing a market of over $3 billion. However, complications following ACL reconstruction are common, including residual pain and knee instability. Furthermore, about 10% of such patients experience a procedural failure that requires a revision surgery and \u00a0there is a three-fold increase in the risk of the early onset of osteoarthritis of the knee following reconstructive surgery. LigaMend is a novel alternative option to ACL reconstruction that stabilizes the torn ACL following surgery and promotes regeneration of connective tissue. Comprised of a bioresorbable magnesium ring, combined with FDA-approved extracellular bioscaffolds (ECM), LigaMend has been shown in pre-clinical trials to fully restore the natural ligament. This technology has the potential to significantly decrease the time and cost of ACL surgery, while improving the outcome for patients.<\/p>\n","protected":false},"excerpt":{"rendered":"

Savio L-Y Woo, PhD, DSc, Deng, Scientific PI Professor of […]<\/p>\n","protected":false},"author":1,"featured_media":422,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[39],"tags":[],"_links":{"self":[{"href":"https:\/\/mirm-pitt.net\/technologies\/wp-json\/wp\/v2\/posts\/421"}],"collection":[{"href":"https:\/\/mirm-pitt.net\/technologies\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mirm-pitt.net\/technologies\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mirm-pitt.net\/technologies\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mirm-pitt.net\/technologies\/wp-json\/wp\/v2\/comments?post=421"}],"version-history":[{"count":1,"href":"https:\/\/mirm-pitt.net\/technologies\/wp-json\/wp\/v2\/posts\/421\/revisions"}],"predecessor-version":[{"id":423,"href":"https:\/\/mirm-pitt.net\/technologies\/wp-json\/wp\/v2\/posts\/421\/revisions\/423"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mirm-pitt.net\/technologies\/wp-json\/wp\/v2\/media\/422"}],"wp:attachment":[{"href":"https:\/\/mirm-pitt.net\/technologies\/wp-json\/wp\/v2\/media?parent=421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mirm-pitt.net\/technologies\/wp-json\/wp\/v2\/categories?post=421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mirm-pitt.net\/technologies\/wp-json\/wp\/v2\/tags?post=421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}